Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102442994A details a novel atmospheric racemization method for S-Lipoic Acid, enabling cost-effective production of high-purity R-Lipoic Acid intermediates.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.
Patent CN108777958B details a novel racemization method for 4-aminoindan derivatives, enabling cost reduction in agrochemical manufacturing by recycling inactive enantiomers.
Novel scalable route for L-penicillamine HCl via efficient racemization and resolution. Delivers high-purity pharmaceutical intermediates with optimized cost structures.
Novel resolution method for high-purity pharmaceutical intermediates. Cost-effective scale-up and supply chain reliability for kinase inhibitor synthesis.
Patent CN114014874B reveals a breakthrough recycling method for Baloxavir intermediates, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN101701222B reveals a robust enzymatic route for (R)-mandelic acid, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN107098866A reveals cost-effective chemical resolution for Lesinurad enantiomers ensuring high purity and supply chain stability for pharmaceutical manufacturing partners globally.
Patent CN107098866A offers cost-effective chiral resolution for Lesinurad intermediates, ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN102285961B details a cost-effective racemization method for duloxetine intermediates, enhancing yield and reducing environmental impact for pharmaceutical manufacturing.
Patent CN113480521B details a novel synthesis route for Bepotastine Besilate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN101823993A reveals a low-cost, high-yield hydrogenation route for L-octahydroindoline-2-formic acid, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN101823993A reveals a low-cost, high-yield hydrogenation route for L-octahydroindoline-2-carboxylic acid, offering significant supply chain advantages for pharma intermediates.
Patent CN104151229B details a high-yield resolution process for Levamlodipine intermediates using DMSO-d6, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN106432195B reveals a streamlined route for (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, enhancing purity and reducing costs.
Patent CN106748825A details a novel synthesis route for Dapoxetine. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN106916074A offers high-purity Tomoxetine Hydrochloride synthesis with recyclable solvents and reduced environmental impact for reliable supply.
Patent CN117658830B enables high-optical-purity trans-2-aminocyclopentanol synthesis. Safe resolution process offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110804062B details a high-yield synthesis of chiral lactone for biotin. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN104628584A reveals a mild synthesis route for dapoxetine. Achieve 99.9% purity with reduced toxicity and significant cost reduction in API manufacturing.